RIL
VKTX icon

Rothschild Investment LLC’s Viking Therapeutics VKTX Stock Holding History

Rothschild Investment LLC’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.03K Buy
52
+44
+550% +$1.42K ﹤0.01% 2761
2026
Q1 		$260 Buy
8
+7
+700% +$225 ﹤0.01% 3256
2025
Q4 		$35 Buy
+1
New +$35 ﹤0.01% 3301
2024
Q3 		– Sell
-30
Closed -$1.59K – 2985
2024
Q2 		$1.59K Buy
30
+20
+200% +$1.31K ﹤0.01% 1473
2024
Q1 		$820 Buy
+10
New +$445 ﹤0.01% 1276

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Rothschild Investment LLC's VKTX Position: Q2 2026 in Review

Rothschild Investment LLC increased its Viking Therapeutics (VKTX) stake by 550% in Q2 2026, buying an estimated $1.42K and bringing the position to 52 shares worth $2.03K. The position accounts for ﹤0.01% of the portfolio, ranked #2761.

Rothschild Investment LLC first reported a position in VKTX in Q1 2024 and has held it in 5 quarters since. 436 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Rothschild Investment LLC held 52 shares of Viking Therapeutics worth $2.03K as of Q2 2026.
  • Rothschild Investment LLC bought 44 Viking Therapeutics shares in Q2 2026, an estimated $1.42K.
  • Viking Therapeutics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2761 holding.
  • Rothschild Investment LLC first reported a position in Viking Therapeutics in Q1 2024 and has held it in 5 quarters since.
  • 436 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.